Arnaud Deladeriere
Arnaud Deladeriere, Ph.D., is principal consultant at Cell&Gene Consulting Inc. Previously, he was head of MSAT and Manufacturing at Triumvira Immunologics, and before that, manufacturing manager at C3i. He received his Ph.D. in biochemistry from the University of Cambridge.
ARTICLES BY ARNAUD DELADERIERE
-
![Computer Science Research Laboratory with Robotic Arm Model-GettyImages-968289652]( "CGT Industrialization Starts With CDMO Alignment")
12/19/2025Fragmented processes are stalling progress. By aligning CDMOs through transparency and standards, developers can move past the COGS obsession and stabilize the supply chain.
-
![scientist smiling with thumbs up-GettyImages-847006300]( "AI Is Not The CMC Revolution You're Looking For, And That's OK")
11/18/2025Advanced therapy development today is less about big funding, more about frugality. Artificial intelligence unlocks a competitive advantage.
-
![Woman adjusting microscope-GettyImages-2181295784]( "Should We Refocus On The Product, Then Engineer The Process?")
10/14/2025Logic behind the "process is the product" refrain collapses when you accept that starting material is non-uniform by design. These experts want to rethink a tired cliche.
-
![vacation-GettyImages-1430503053]( "New Group Wants 'Phase-Appropriate' Thinking To Retire")
9/4/2025Decisions in cell and gene therapy are not about aligning with arbitrary clinical phases but about balancing risk.
